25 XP   0   0   10

Bliss GVS Pharma Limited
Buy, Hold or Sell?

Let's analyse Bliss GVS Pharma Limited together

PenkeI guess you are interested in Bliss GVS Pharma Limited. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Bliss GVS Pharma Limited. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Bliss GVS Pharma Limited

I send you an email if I find something interesting about Bliss GVS Pharma Limited.

Quick analysis of Bliss GVS Pharma Limited (30 sec.)










What can you expect buying and holding a share of Bliss GVS Pharma Limited? (30 sec.)

How much money do you get?

How much money do you get?
INR0.02
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
INR86.98
Expected worth in 1 year
INR113.04
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
INR28.12
Return On Investment
24.9%

For what price can you sell your share?

Current Price per Share
INR112.85
Expected price per share
INR101.95 - INR149.60
How sure are you?
50%

1. Valuation of Bliss GVS Pharma Limited (5 min.)




Live pricePrice per Share (EOD)

INR112.85

Intrinsic Value Per Share

INR-46.49 - INR4.63

Total Value Per Share

INR40.49 - INR91.61

2. Growth of Bliss GVS Pharma Limited (5 min.)




Is Bliss GVS Pharma Limited growing?

Current yearPrevious yearGrowGrow %
How rich?$110m$101.5m$8.5m7.7%

How much money is Bliss GVS Pharma Limited making?

Current yearPrevious yearGrowGrow %
Making money$8.5m$1.8m$6.6m78.8%
Net Profit Margin9.4%2.0%--

How much money comes from the company's main activities?

3. Financial Health of Bliss GVS Pharma Limited (5 min.)




What can you expect buying and holding a share of Bliss GVS Pharma Limited? (5 min.)

Welcome investor! Bliss GVS Pharma Limited's management wants to use your money to grow the business. In return you get a share of Bliss GVS Pharma Limited.

What can you expect buying and holding a share of Bliss GVS Pharma Limited?

First you should know what it really means to hold a share of Bliss GVS Pharma Limited. And how you can make/lose money.

Speculation

The Price per Share of Bliss GVS Pharma Limited is INR112.85. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Bliss GVS Pharma Limited.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Bliss GVS Pharma Limited, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is INR86.98. Based on the TTM, the Book Value Change Per Share is INR6.52 per quarter. Based on the YOY, the Book Value Change Per Share is INR1.97 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is INR0.52 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Bliss GVS Pharma Limited.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 INR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per Share
Usd Eps0.080.1%0.080.1%0.020.0%0.090.1%0.080.1%
Usd Book Value Change Per Share0.080.1%0.080.1%0.020.0%0.080.1%0.070.1%
Usd Dividend Per Share0.010.0%0.010.0%0.010.0%0.010.0%0.010.0%
Usd Total Gains Per Share0.080.1%0.080.1%0.030.0%0.090.1%0.080.1%
Usd Price Per Share0.85-0.85-0.93-1.26-1.44-
Price to Earnings Ratio10.59-10.59-53.93-21.15-21.32-
Price-to-Total Gains Ratio10.12-10.12-31.14-16.11-43.85-
Price to Book Ratio0.82-0.82-0.96-1.46-2.28-
Price-to-Total Gains Ratio10.12-10.12-31.14-16.11-43.85-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.3542
Number of shares738
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.010.01
Usd Book Value Change Per Share0.080.08
Usd Total Gains Per Share0.080.09
Gains per Quarter (738 shares)62.2767.64
Gains per Year (738 shares)249.07270.56
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
11823123925246261
23746248850491532
35569273775737803
4739239861009821074
5911154123512512281345
61101385148415014731616
71281616173317517191887
81461846198220019642158
91642077223122522102429
101832308248025024562700

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%17.00.00.0100.0%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%9.01.00.090.0%16.01.00.094.1%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%17.00.00.0100.0%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%17.00.00.0100.0%

Fundamentals of Bliss GVS Pharma Limited

About Bliss GVS Pharma Limited

Bliss GVS Pharma Limited develops, manufactures, and markets pharmaceutical formulations in India. It offers pharma products, including capsules, creams/gels/ointments, dry powder for injections and oral suspensions, effervescent tablets, eye/ear drops, injections, liquid preparations, lotions, lozenges, nasal solutions, oral solids, parenterals, pessaries, sachets, soft gelatin capsules, suppositories, suspensions, syrups, tablets, topical preparations, and transdermal patches. The company provides other healthcare products, such as balms, creams, lotions, lozenges, nasal inhalers, over the counter products, petroleum jellies, powders, roll-ons, shampoos, soaps, solutions, sprays, syrups, and vaginal washes. In addition, it offers therapeutic products consisting of anti-bacterial, anti-dandruff shampoo, amino acid preparation, iron tonic, antitussive, appetite stimulant, anti-allergic, body supplement, anti-biotic, anti-diabetic, anti-diarrheal, anti-emetic, anti-fungal, anti-haemorrhoidal, anti-helmintic, anti-infective, anti-inflammatory, anti-malarial, anti-microbial, anti-migraine, anti-oxidant, anti-protozoal, ear wax solvent, anti-pyretic, anti-septic, anti-spasmodic, anti-ulcer, and anti-ulcerant; and analgesic, oral rehydration, antacid, anxiolytic, appetizer, cough syrup, erectile dysfunction, haematinic, hand sanitizer, health supplement, insecticide, laryngitis, pharyngitis, laxative, lubricant, mosquito repellant, nasal decongestant, nutritional supplement, moisturizer, prickly heat powder, skin lightening lotion, vaginal contraceptive, vaginal hygiene, and vitamin supplements, as well as soaps. The company exports its products. Bliss GVS Pharma Limited was incorporated in 1984 and is based in Mumbai, India.

Fundamental data was last updated by Penke on 2024-03-07 12:06:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating efficient.
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is underpriced.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Bliss GVS Pharma Limited.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Bliss GVS Pharma Limited earns for each ₹1 of revenue.

  • Above 10% is considered healthy but always compare Bliss GVS Pharma Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 9.4% means that ₹0.09 for each ₹1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Bliss GVS Pharma Limited:

  • The MRQ is 9.4%. The company is making a profit. +1
  • The TTM is 9.4%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ9.4%TTM9.4%0.0%
TTM9.4%YOY2.0%+7.4%
TTM9.4%5Y9.7%-0.3%
5Y9.7%10Y11.7%-2.0%
1.1.2. Return on Assets

Shows how efficient Bliss GVS Pharma Limited is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Bliss GVS Pharma Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • 6.1% Return on Assets means that Bliss GVS Pharma Limited generated ₹0.06 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Bliss GVS Pharma Limited:

  • The MRQ is 6.1%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 6.1%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ6.1%TTM6.1%0.0%
TTM6.1%YOY1.4%+4.8%
TTM6.1%5Y6.8%-0.7%
5Y6.8%10Y7.6%-0.8%
1.1.3. Return on Equity

Shows how efficient Bliss GVS Pharma Limited is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Bliss GVS Pharma Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • 8.0% Return on Equity means Bliss GVS Pharma Limited generated ₹0.08 for each ₹1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Bliss GVS Pharma Limited:

  • The MRQ is 8.0%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 8.0%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ8.0%TTM8.0%0.0%
TTM8.0%YOY1.8%+6.2%
TTM8.0%5Y9.3%-1.3%
5Y9.3%10Y12.7%-3.4%

1.2. Operating Efficiency of Bliss GVS Pharma Limited.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Bliss GVS Pharma Limited is operating .

  • Measures how much profit Bliss GVS Pharma Limited makes for each ₹1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Bliss GVS Pharma Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 15.5% means the company generated ₹0.15  for each ₹1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Bliss GVS Pharma Limited:

  • The MRQ is 15.5%. The company is operating efficient. +1
  • The TTM is 15.5%. The company is operating efficient. +1
Trends
Current periodCompared to+/- 
MRQ15.5%TTM15.5%0.0%
TTM15.5%YOY20.0%-4.5%
TTM15.5%5Y19.8%-4.3%
5Y19.8%10Y22.0%-2.2%
1.2.2. Operating Ratio

Measures how efficient Bliss GVS Pharma Limited is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 0.87 means that the operating costs are ₹0.87 for each ₹1 in net sales.

Let's take a look of the Operating Ratio trends of Bliss GVS Pharma Limited:

  • The MRQ is 0.869. The company is less efficient in keeping operating costs low.
  • The TTM is 0.869. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ0.869TTM0.8690.000
TTM0.869YOY0.840+0.029
TTM0.8695Y0.840+0.028
5Y0.84010Y0.806+0.035

1.3. Liquidity of Bliss GVS Pharma Limited.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Bliss GVS Pharma Limited is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 3.61 means the company has ₹3.61 in assets for each ₹1 in short-term debts.

Let's take a look of the Current Ratio trends of Bliss GVS Pharma Limited:

  • The MRQ is 3.608. The company is very able to pay all its short-term debts. +2
  • The TTM is 3.608. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ3.608TTM3.6080.000
TTM3.608YOY3.329+0.279
TTM3.6085Y3.475+0.133
5Y3.47510Y2.642+0.833
1.3.2. Quick Ratio

Measures if Bliss GVS Pharma Limited is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Bliss GVS Pharma Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 3.03 means the company can pay off ₹3.03 for each ₹1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Bliss GVS Pharma Limited:

  • The MRQ is 3.033. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 3.033. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ3.033TTM3.0330.000
TTM3.033YOY3.027+0.007
TTM3.0335Y3.131-0.097
5Y3.13110Y2.283+0.848

1.4. Solvency of Bliss GVS Pharma Limited.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Bliss GVS Pharma Limited assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Bliss GVS Pharma Limited to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.21 means that Bliss GVS Pharma Limited assets are financed with 20.7% credit (debt) and the remaining percentage (100% - 20.7%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Bliss GVS Pharma Limited:

  • The MRQ is 0.207. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.207. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.207TTM0.2070.000
TTM0.207YOY0.237-0.030
TTM0.2075Y0.243-0.036
5Y0.24310Y0.340-0.096
1.4.2. Debt to Equity Ratio

Measures if Bliss GVS Pharma Limited is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Bliss GVS Pharma Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 27.1% means that company has ₹0.27 debt for each ₹1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Bliss GVS Pharma Limited:

  • The MRQ is 0.271. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.271. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.271TTM0.2710.000
TTM0.271YOY0.320-0.049
TTM0.2715Y0.331-0.061
5Y0.33110Y0.583-0.251

2. Market Valuation of Bliss GVS Pharma Limited

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₹1 in earnings Bliss GVS Pharma Limited generates.

  • Above 15 is considered overpriced but always compare Bliss GVS Pharma Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 10.59 means the investor is paying ₹10.59 for every ₹1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Bliss GVS Pharma Limited:

  • The EOD is 16.799. Based on the earnings, the company is fair priced.
  • The MRQ is 10.591. Based on the earnings, the company is underpriced. +1
  • The TTM is 10.591. Based on the earnings, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD16.799MRQ10.591+6.207
MRQ10.591TTM10.5910.000
TTM10.591YOY53.929-43.338
TTM10.5915Y21.146-10.555
5Y21.14610Y21.321-0.175
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Bliss GVS Pharma Limited:

  • The EOD is -20.010. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -12.616. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -12.616. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-20.010MRQ-12.616-7.394
MRQ-12.616TTM-12.6160.000
TTM-12.616YOY13.193-25.810
TTM-12.6165Y-108.551+95.934
5Y-108.55110Y-54.739-53.812
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Bliss GVS Pharma Limited is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A PB ratio of 0.82 means the investor is paying ₹0.82 for each ₹1 in book value.

Let's take a look of the Price to Book Ratio trends of Bliss GVS Pharma Limited:

  • The EOD is 1.297. Based on the equity, the company is underpriced. +1
  • The MRQ is 0.818. Based on the equity, the company is cheap. +2
  • The TTM is 0.818. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD1.297MRQ0.818+0.479
MRQ0.818TTM0.8180.000
TTM0.818YOY0.958-0.140
TTM0.8185Y1.457-0.639
5Y1.45710Y2.278-0.821
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Bliss GVS Pharma Limited compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--6.5166.5160%1.970+231%6.932-6%6.101+7%
Book Value Per Share--86.97786.9770%80.461+8%76.127+14%58.987+47%
Current Ratio--3.6083.6080%3.329+8%3.475+4%2.642+37%
Debt To Asset Ratio--0.2070.2070%0.237-13%0.243-15%0.340-39%
Debt To Equity Ratio--0.2710.2710%0.320-15%0.331-18%0.583-54%
Dividend Per Share--0.5150.5150%0.506+2%0.706-27%0.672-23%
Eps--6.7186.7180%1.430+370%7.150-6%6.672+1%
Free Cash Flow Per Share---5.640-5.6400%5.844-197%0.721-883%2.838-299%
Free Cash Flow To Equity Per Share---8.004-8.0040%3.588-323%-0.349-96%0.563-1521%
Gross Profit Margin--0.4050.4050%-2.004+595%0.133+203%0.541-25%
Intrinsic Value_10Y_max--4.632--------
Intrinsic Value_10Y_min---46.486--------
Intrinsic Value_1Y_max--2.331--------
Intrinsic Value_1Y_min---0.642--------
Intrinsic Value_3Y_max--5.582--------
Intrinsic Value_3Y_min---5.419--------
Intrinsic Value_5Y_max--7.117--------
Intrinsic Value_5Y_min---13.984--------
Market Cap11814379350.000+36%7504821956.2507504821956.2500%8111002728.300-7%11070060402.030-32%12575499951.015-40%
Net Profit Margin--0.0940.0940%0.020+363%0.097-3%0.117-20%
Operating Margin--0.1550.1550%0.200-23%0.198-22%0.220-30%
Operating Ratio--0.8690.8690%0.840+3%0.840+3%0.806+8%
Pb Ratio1.297+37%0.8180.8180%0.958-15%1.457-44%2.278-64%
Pe Ratio16.799+37%10.59110.5910%53.929-80%21.146-50%21.321-50%
Price Per Share112.850+37%71.15071.1500%77.100-8%105.410-33%119.955-41%
Price To Free Cash Flow Ratio-20.010-59%-12.616-12.6160%13.193-196%-108.551+760%-54.739+334%
Price To Total Gains Ratio16.050+37%10.11910.1190%31.136-67%16.105-37%43.854-77%
Quick Ratio--3.0333.0330%3.027+0%3.131-3%2.283+33%
Return On Assets--0.0610.0610%0.014+352%0.068-10%0.076-20%
Return On Equity--0.0800.0800%0.018+336%0.093-14%0.127-37%
Total Gains Per Share--7.0317.0310%2.476+184%7.638-8%6.773+4%
Usd Book Value--110090820.000110090820.0000%101575440.000+8%96048717.600+15%74310892.800+48%
Usd Book Value Change Per Share--0.0780.0780%0.024+231%0.083-6%0.073+7%
Usd Book Value Per Share--1.0441.0440%0.966+8%0.914+14%0.708+47%
Usd Dividend Per Share--0.0060.0060%0.006+2%0.008-27%0.008-23%
Usd Eps--0.0810.0810%0.017+370%0.086-6%0.080+1%
Usd Free Cash Flow---7138260.000-7138260.0000%7377300.000-197%911601.600-883%3568488.000-300%
Usd Free Cash Flow Per Share---0.068-0.0680%0.070-197%0.009-883%0.034-299%
Usd Free Cash Flow To Equity Per Share---0.096-0.0960%0.043-323%-0.004-96%0.007-1521%
Usd Market Cap141772552.200+36%90057863.47590057863.4750%97332032.740-7%132840724.824-32%150905999.412-40%
Usd Price Per Share1.354+37%0.8540.8540%0.925-8%1.265-33%1.439-41%
Usd Profit--8503056.0008503056.0000%1804824.000+371%8374077.600+2%8120397.600+5%
Usd Revenue--90190500.00090190500.0000%88551420.000+2%87029349.600+4%73088222.400+23%
Usd Total Gains Per Share--0.0840.0840%0.030+184%0.092-8%0.081+4%
 EOD+5 -3MRQTTM+0 -0YOY+25 -115Y+12 -2410Y+18 -18

3.2. Fundamental Score

Let's check the fundamental score of Bliss GVS Pharma Limited based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1516.799
Price to Book Ratio (EOD)Between0-11.297
Net Profit Margin (MRQ)Greater than00.094
Operating Margin (MRQ)Greater than00.155
Quick Ratio (MRQ)Greater than13.033
Current Ratio (MRQ)Greater than13.608
Debt to Asset Ratio (MRQ)Less than10.207
Debt to Equity Ratio (MRQ)Less than10.271
Return on Equity (MRQ)Greater than0.150.080
Return on Assets (MRQ)Greater than0.050.061
Total7/10 (70.0%)

3.3. Technical Score

Let's check the technical score of Bliss GVS Pharma Limited based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5047.290
Ma 20Greater thanMa 50114.105
Ma 50Greater thanMa 100118.738
Ma 100Greater thanMa 200123.798
OpenGreater thanClose115.800
Total2/5 (40.0%)



Latest Balance Sheet

Balance Sheet of 2023-03-31. Currency in INR. All numbers in thousands.

Summary
Total Assets11,568,526
Total Liabilities2,394,291
Total Stockholder Equity8,838,969
 As reported
Total Liabilities 2,394,291
Total Stockholder Equity+ 8,838,969
Total Assets = 11,568,526

Assets

Total Assets11,568,526
Total Current Assets6,973,664
Long-term Assets4,594,862
Total Current Assets
Cash And Cash Equivalents 249,552
Short-term Investments 872,000
Net Receivables 3,868,856
Inventory 1,030,635
Other Current Assets 952,621
Total Current Assets  (as reported)6,973,664
Total Current Assets  (calculated)6,973,664
+/-0
Long-term Assets
Property Plant Equipment 3,729,121
Goodwill 77,111
Intangible Assets 2,294
Long-term Assets Other 184,418
Long-term Assets  (as reported)4,594,862
Long-term Assets  (calculated)3,992,944
+/- 601,918

Liabilities & Shareholders' Equity

Total Current Liabilities1,932,590
Long-term Liabilities461,701
Total Stockholder Equity8,838,969
Total Current Liabilities
Short-term Debt 584,907
Short Long Term Debt 573,772
Accounts payable 863,899
Other Current Liabilities 63,141
Total Current Liabilities  (as reported)1,932,590
Total Current Liabilities  (calculated)2,085,719
+/- 153,129
Long-term Liabilities
Long term Debt Total 434,071
Capital Lease Obligations 38,309
Long-term Liabilities  (as reported)461,701
Long-term Liabilities  (calculated)472,380
+/- 10,679
Total Stockholder Equity
Common Stock104,153
Retained Earnings 8,149,244
Accumulated Other Comprehensive Income 315,629
Capital Surplus 269,943
Total Stockholder Equity (as reported)8,838,969
Total Stockholder Equity (calculated)8,838,969
+/-0
Other
Capital Stock104,153
Cash And Equivalents24,694
Cash and Short Term Investments 1,121,552
Common Stock Shares Outstanding 105,479
Current Deferred Revenue420,643
Liabilities and Stockholders Equity 11,568,526
Net Debt 769,426
Net Invested Capital 9,819,638
Net Working Capital 5,041,074
Property Plant and Equipment Gross 3,729,121
Short Long Term Debt Total 1,018,978



Balance Sheet

Currency in INR. All numbers in thousands.

 Trend2023-03-312022-03-312021-03-312020-03-312019-03-312018-03-312017-03-312016-03-312015-03-312014-03-312013-03-312012-03-312011-03-312010-03-312009-03-312008-03-312007-03-31
> Total Assets 
575,845
907,678
1,268,970
1,590,128
2,134,948
3,097,468
5,851,268
5,827,856
6,621,682
7,617,818
9,860,844
8,600,341
9,048,770
10,290,236
10,767,858
11,087,466
11,568,526
11,568,52611,087,46610,767,85810,290,2369,048,7708,600,3419,860,8447,617,8186,621,6825,827,8565,851,2683,097,4682,134,9481,590,1281,268,970907,678575,845
   > Total Current Assets 
419,941
760,293
1,024,020
1,351,221
1,839,376
2,114,386
3,605,880
3,542,332
4,170,776
4,705,482
5,356,931
6,874,266
6,936,150
7,729,493
7,651,996
7,760,341
6,973,664
6,973,6647,760,3417,651,9967,729,4936,936,1506,874,2665,356,9314,705,4824,170,7763,542,3323,605,8802,114,3861,839,3761,351,2211,024,020760,293419,941
       Cash And Cash Equivalents 
41,246
60,020
68,489
153,222
179,830
580,056
497,182
803,721
572,893
781,766
1,505,097
428,571
150,393
150,923
126,347
219,152
249,552
249,552219,152126,347150,923150,393428,5711,505,097781,766572,893803,721497,182580,056179,830153,22268,48960,02041,246
       Short-term Investments 
0
0
0
0
0
8,026
0
0
0
0
214,946
115,529
718,241
248,797
495,316
1,239,557
872,000
872,0001,239,557495,316248,797718,241115,529214,94600008,02600000
       Net Receivables 
0
0
0
0
0
0
0
2,248,029
2,639,879
3,009,329
2,935,095
4,142,440
4,953,029
6,588,170
5,639,071
4,356,992
3,868,856
3,868,8564,356,9925,639,0716,588,1704,953,0294,142,4402,935,0953,009,3292,639,8792,248,0290000000
       Inventory 
34,048
191,267
386,928
306,729
116,113
126,809
325,233
325,304
337,000
386,730
492,987
590,335
773,674
741,380
989,274
1,239,422
1,030,635
1,030,6351,239,422989,274741,380773,674590,335492,987386,730337,000325,304325,233126,809116,113306,729386,928191,26734,048
       Other Current Assets 
344,647
509,006
568,603
891,270
1,543,433
1,399,495
2,783,465
2,413,307
3,260,883
3,536,986
3,358,847
5,739,831
5,293,842
223
401,988
705,218
952,621
952,621705,218401,9882235,293,8425,739,8313,358,8473,536,9863,260,8832,413,3072,783,4651,399,4951,543,433891,270568,603509,006344,647
   > Long-term Assets 
155,904
147,385
244,950
238,907
295,572
983,082
2,245,388
2,285,524
2,450,906
2,912,336
4,503,913
1,726,075
2,112,620
2,560,743
3,115,862
3,327,125
4,594,862
4,594,8623,327,1253,115,8622,560,7432,112,6201,726,0754,503,9132,912,3362,450,9062,285,5242,245,388983,082295,572238,907244,950147,385155,904
       Property Plant Equipment 
155,903
147,384
244,949
236,151
274,827
421,518
926,152
1,431,824
1,598,264
1,900,162
2,591,705
1,267,794
1,815,374
2,326,162
2,278,234
2,948,237
3,729,121
3,729,1212,948,2372,278,2342,326,1621,815,3741,267,7942,591,7051,900,1621,598,2641,431,824926,152421,518274,827236,151244,949147,384155,903
       Goodwill 
0
0
0
0
0
0
0
736,964
737,600
437,564
424,308
96,477
96,477
77,111
77,111
77,111
77,111
77,11177,11177,11177,11196,47796,477424,308437,564737,600736,9640000000
       Long Term Investments 
0
0
0
0
0
0
0
101
101
1,102
1,939
246
294
0
0
0
0
00002942461,9391,1021011010000000
       Intangible Assets 
0
0
0
0
0
47,840
0
7,612
7,937
5,760
66,263
5,178
5,268
6,423
5,785
3,828
2,294
2,2943,8285,7856,4235,2685,17866,2635,7607,9377,612047,84000000
       Long-term Assets Other 
1
1
1
1
17,001
521,749
1,319,236
853,700
852,642
1,012,174
1,912,208
471,909
913,448
105,084
106,669
233,224
184,418
184,418233,224106,669105,084913,448471,9091,912,2081,012,174852,642853,7001,319,236521,74917,0011111
> Total Liabilities 
340,533
288,896
293,776
258,054
468,739
990,860
3,133,225
2,857,418
3,101,934
3,160,637
4,379,940
3,123,167
2,450,141
2,786,515
2,488,764
2,622,846
2,394,291
2,394,2912,622,8462,488,7642,786,5152,450,1413,123,1674,379,9403,160,6373,101,9342,857,4183,133,225990,860468,739258,054293,776288,896340,533
   > Total Current Liabilities 
263,612
251,481
264,210
181,633
386,345
597,414
2,084,906
1,904,033
2,426,774
2,665,181
3,814,246
2,993,960
2,070,252
2,321,844
2,036,358
2,330,862
1,932,590
1,932,5902,330,8622,036,3582,321,8442,070,2522,993,9603,814,2462,665,1812,426,7741,904,0332,084,906597,414386,345181,633264,210251,481263,612
       Short-term Debt 
0
0
0
0
0
0
560,424
570,490
610,421
621,238
1,419,241
1,120,385
694,021
857,679
874,665
826,767
584,907
584,907826,767874,665857,679694,0211,120,3851,419,241621,238610,421570,490560,424000000
       Short Long Term Debt 
0
0
0
0
0
0
0
1,725,678
412,472
311,429
1,419,241
1,120,385
694,021
837,247
650,377
817,350
573,772
573,772817,350650,377837,247694,0211,120,3851,419,241311,429412,4721,725,6780000000
       Accounts payable 
0
0
0
0
0
0
1,193,628
823,544
803,339
1,084,857
944,687
584,334
789,488
941,536
742,247
926,061
863,899
863,899926,061742,247941,536789,488584,334944,6871,084,857803,339823,5441,193,628000000
       Other Current Liabilities 
263,612
251,481
264,210
181,633
386,345
597,414
330,854
509,999
1,013,014
959,086
1,450,318
1,221,546
491,840
7,992
1,576
911
63,141
63,1419111,5767,992491,8401,221,5461,450,318959,0861,013,014509,999330,854597,414386,345181,633264,210251,481263,612
   > Long-term Liabilities 
76,921
37,415
29,566
76,421
82,394
393,446
1,048,319
953,385
675,160
495,456
565,694
129,207
379,889
464,671
452,406
291,984
461,701
461,701291,984452,406464,671379,889129,207565,694495,456675,160953,3851,048,319393,44682,39476,42129,56637,41576,921
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
382,427
255,804
59,155
325,375
403,586
344,330
267,141
434,071
434,071267,141344,330403,586325,37559,155255,804382,427000000000
       Other Liabilities 
0
0
0
0
0
0
0
80,612
102,579
113,029
72,302
70,052
54,513
61,085
108,075
24,843
0
024,843108,07561,08554,51370,05272,302113,029102,57980,6120000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
14,236
4,326
0
0
0
0
0
0
0
0
000000004,32614,2360000000
> Total Stockholder Equity
235,313
618,783
975,193
1,332,073
1,666,209
2,106,608
2,580,057
2,868,812
3,370,830
4,126,224
4,832,256
5,362,393
6,459,986
7,356,130
8,082,534
8,187,017
8,838,969
8,838,9698,187,0178,082,5347,356,1306,459,9865,362,3934,832,2564,126,2243,370,8302,868,8122,580,0572,106,6081,666,2091,332,073975,193618,783235,313
   Common Stock
63,067
64,467
103,147
103,147
103,147
103,147
103,147
103,147
103,147
103,147
103,147
103,147
103,147
103,147
103,147
103,678
104,153
104,153103,678103,147103,147103,147103,147103,147103,147103,147103,147103,147103,147103,147103,147103,14764,46763,067
   Retained Earnings Total Equity00000000000000000
   Accumulated Other Comprehensive Income 
-36,748
-66,014
-101,732
-155,743
-209,087
-34,549
-142,003
-236,754
-338,054
-495,751
-658,122
-205,131
-243,151
-341,542
459,530
383,421
315,629
315,629383,421459,530-341,542-243,151-205,131-658,122-495,751-338,054-236,754-142,003-34,549-209,087-155,743-101,732-66,014-36,748
   Capital Surplus 
0
0
0
0
0
0
0
0
0
147,573
147,573
147,573
147,573
147,573
147,573
212,768
269,943
269,943212,768147,573147,573147,573147,573147,573147,573000000000
   Treasury Stock00000000000000000
   Other Stockholders Equity 
208,994
620,330
973,778
1,384,669
1,772,149
2,038,010
502,664
598,835
750,334
956,513
1,028,810
697,974
720,998
-7,291,010
147,573
212,768
269,943
269,943212,768147,573-7,291,010720,998697,9741,028,810956,513750,334598,835502,6642,038,0101,772,1491,384,669973,778620,330208,994



Balance Sheet

Currency in INR. All numbers in thousands.




Cash Flow

Currency in INR. All numbers in thousands.




Income Statement

Currency in INR. All numbers in thousands.


Latest Income Statement (annual, 2023-03-31)

Gross Profit (+$)
totalRevenue7,515,875
Cost of Revenue-4,013,249
Gross Profit3,502,6263,502,626
 
Operating Income (+$)
Gross Profit3,502,626
Operating Expense-2,516,134
Operating Income986,492986,492
 
Operating Expense (+$)
Research Development217,888
Selling General Administrative72,765
Selling And Marketing Expenses421,652
Operating Expense2,516,134712,305
 
Net Interest Income (+$)
Interest Income103,640
Interest Expense-103,640
Other Finance Cost-103,640
Net Interest Income-103,640
 
Pretax Income (+$)
Operating Income986,492
Net Interest Income-103,640
Other Non-Operating Income Expenses0
Income Before Tax (EBT)1,060,716912,268
EBIT - interestExpense = 1,060,716
1,000,130
812,228
Interest Expense103,640
Earnings Before Interest and Taxes (EBIT)1,164,3561,164,356
Earnings Before Interest and Taxes (EBITDA)1,351,089
 
After tax Income (+$)
Income Before Tax1,060,716
Tax Provision-291,542
Net Income From Continuing Ops769,174769,174
Net Income708,588
Net Income Applicable To Common Shares708,588
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses6,529,383
Total Other Income/Expenses Net74,224103,640
 

Technical Analysis of Bliss GVS Pharma Limited
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Bliss GVS Pharma Limited. The general trend of Bliss GVS Pharma Limited is BEARISH with 14.3% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Bliss GVS Pharma Limited's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-14.3%) Bearish trend (14.3%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Bliss GVS Pharma Limited.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 137.55 < 142.40 < 149.60.

The bearish price targets are: 104.00 > 103.00 > 101.95.

Tweet this
Bliss GVS Pharma Limited Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Bliss GVS Pharma Limited. The current mas is .

The long score for the Moving Averages is 6/14.
The longshort score for the Moving Averages is -2/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Bliss GVS Pharma Limited Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Bliss GVS Pharma Limited. The current macd is -2.69651579.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Bliss GVS Pharma Limited price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Bliss GVS Pharma Limited. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Bliss GVS Pharma Limited price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Bliss GVS Pharma Limited Daily Moving Average Convergence/Divergence (MACD) ChartBliss GVS Pharma Limited Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Bliss GVS Pharma Limited. The current adx is 12.48.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Bliss GVS Pharma Limited shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Bliss GVS Pharma Limited Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Bliss GVS Pharma Limited. The current sar is 102.56.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Bliss GVS Pharma Limited Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Bliss GVS Pharma Limited. The current rsi is 47.29. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Bliss GVS Pharma Limited Daily Relative Strength Index (RSI) ChartBliss GVS Pharma Limited Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Bliss GVS Pharma Limited. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 2/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Bliss GVS Pharma Limited price going up in the near term. +2
  • Trending down: The STOCH %K is trending down. -1
Bliss GVS Pharma Limited Daily Stochastic Oscillator ChartBliss GVS Pharma Limited Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Bliss GVS Pharma Limited. The current cci is -13.94279976.

Bliss GVS Pharma Limited Daily Commodity Channel Index (CCI) ChartBliss GVS Pharma Limited Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Bliss GVS Pharma Limited. The current cmo is -2.23945068.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Bliss GVS Pharma Limited Daily Chande Momentum Oscillator (CMO) ChartBliss GVS Pharma Limited Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Bliss GVS Pharma Limited. The current willr is -53.14814815.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Bliss GVS Pharma Limited is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Bliss GVS Pharma Limited Daily Williams %R ChartBliss GVS Pharma Limited Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Bliss GVS Pharma Limited.

Bliss GVS Pharma Limited Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Bliss GVS Pharma Limited. The current atr is 7.24639914.

Bliss GVS Pharma Limited Daily Average True Range (ATR) ChartBliss GVS Pharma Limited Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Bliss GVS Pharma Limited. The current obv is 58,555,154.

Bliss GVS Pharma Limited Daily On-Balance Volume (OBV) ChartBliss GVS Pharma Limited Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Bliss GVS Pharma Limited. The current mfi is 52.77.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Bliss GVS Pharma Limited Daily Money Flow Index (MFI) ChartBliss GVS Pharma Limited Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Bliss GVS Pharma Limited.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-06RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-07STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-08STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-10STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-13ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-15STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-20STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-22STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-24STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-28STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-01STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-04STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-06SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-07CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-08STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-11STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-12WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-13STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-14STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-15CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-20DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-02DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-12WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-15DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-16MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-17MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-23STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-24CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-31STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-02STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-05DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-02-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-07STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-08STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-02-13MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-16DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-19CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-20STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-21MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-23STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-27STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-28CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-29CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-11DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-13STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-19WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-20MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-21SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-03-26DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-27MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-28CMO SHORT ENTRY LONG CLOSEZero line crossover to downside

6.3. Candlestick Patterns

Bliss GVS Pharma Limited Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Bliss GVS Pharma Limited based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5047.290
Ma 20Greater thanMa 50114.105
Ma 50Greater thanMa 100118.738
Ma 100Greater thanMa 200123.798
OpenGreater thanClose115.800
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Bliss GVS Pharma Limited with someone you think should read this too:
  • Are you bullish or bearish on Bliss GVS Pharma Limited? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Bliss GVS Pharma Limited? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Bliss GVS Pharma Limited

I send you an email if I find something interesting about Bliss GVS Pharma Limited.


Comments

How you think about this?

Leave a comment

Stay informed about Bliss GVS Pharma Limited.

Receive notifications about Bliss GVS Pharma Limited in your mailbox!